miRNA在肝癌中的价值

[1] Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma [J]. CANCER, 2012, 118 (09) : 2431 - 2442

[2] Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (16) : 3442 - 3449

[3] Serum micro RNAprofiles as prognostic biomarkers for HBV-positive hepatocellular carcinoma. ZHU HT,HASANAM,LIU RB,et al. Oncotarget . 2016

[4] Octamer 4/micro RNA-1246 signaling axis drives Wnt/beta-catenin activation in liver cancer stem cells. CHAI S,NG K Y,TONG M,et al. Hepatology . 2016

[5] Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model [J]. CELL, 2009, 137 (06) : 1005 - 1017

[6] Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (01) : 153 - 161

[7] MicroRNA‐122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β‐catenin pathway[J] . XiumingZhu,RongYang,QiangfengWang. &nbspLiver Int . 2012 (5)

[8] Modulation of miR-29 Expression by Alpha-Fetoprotein Is Linked to the Hepatocellular Carcinoma Epigenome [J]. HEPATOLOGY, 2014, 60 (03) : 872 - 883

[9] Micro RNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib. Stiuso P,Potenza N,Lombardi A,Ferrandino I,Monaco A,Zappavigna S,Vanacore D,Mosca N,Castiello F,Porto S,Addeo R,Prete SD,Vita FD,Russo A,Caraglia M. Molecular Therapy-Nucleic Acids . 2015

[10] Micro RNAs in liver cancer:a model for investigating pathogenesis and novel therapeutic approaches. Callegari E,Gramantieri L,Domenicali M,et al. Cell Death and Differentiation . 2015

[1] Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma [J]. CANCER, 2012, 118 (09) : 2431 - 2442

[2] Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (16) : 3442 - 3449

[3] Serum micro RNAprofiles as prognostic biomarkers for HBV-positive hepatocellular carcinoma. ZHU HT,HASANAM,LIU RB,et al. Oncotarget . 2016

[4] Octamer 4/micro RNA-1246 signaling axis drives Wnt/beta-catenin activation in liver cancer stem cells. CHAI S,NG K Y,TONG M,et al. Hepatology . 2016

[5] Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model [J]. CELL, 2009, 137 (06) : 1005 - 1017

[6] Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (01) : 153 - 161

[7] MicroRNA‐122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β‐catenin pathway[J] . XiumingZhu,RongYang,QiangfengWang. &nbspLiver Int . 2012 (5)

[8] Modulation of miR-29 Expression by Alpha-Fetoprotein Is Linked to the Hepatocellular Carcinoma Epigenome [J]. HEPATOLOGY, 2014, 60 (03) : 872 - 883

[9] Micro RNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib. Stiuso P,Potenza N,Lombardi A,Ferrandino I,Monaco A,Zappavigna S,Vanacore D,Mosca N,Castiello F,Porto S,Addeo R,Prete SD,Vita FD,Russo A,Caraglia M. Molecular Therapy-Nucleic Acids . 2015

[10] Micro RNAs in liver cancer:a model for investigating pathogenesis and novel therapeutic approaches. Callegari E,Gramantieri L,Domenicali M,et al. Cell Death and Differentiation . 2015